Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU

NCT06588101 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2025-06-04

No results posted yet for this study

Summary

There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).

Conditions

  • Family Members
  • Recruitment
  • Clinical Study
  • Retention
  • Recruitment of Participants
  • Study Enrollment
  • Retention of Participants
  • Compensation Incentives

Interventions

OTHER

Written informed consent with infographic

Potential participants are provided a visual infographic depicting the key elements of the written consent form in addition to the standard written consent form.

OTHER

Compensation

Potential participants are provided an e-gift card to Amazon or Second Cup as a reward for completing the enrollment questionnaire.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • Lady Davis Institute

    lead OTHER

Principal Investigators

  • Michael J Goldfarb, MD, MSc · Lady Davis Institute, McGill University, Jewish General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2026-04-30
Completion
2026-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06588101 on ClinicalTrials.gov